• <small id="eqkgy"><blockquote id="eqkgy"></blockquote></small>
    <input id="eqkgy"><samp id="eqkgy"></samp></input>
  • <kbd id="eqkgy"><strong id="eqkgy"></strong></kbd><option id="eqkgy"></option>
  • <samp id="eqkgy"><label id="eqkgy"></label></samp>
  • <u id="eqkgy"></u>
  • 歡迎訪問云南西力生物技術股份有限公司!證券代碼:871574
    首頁 成 果 源于西力產品的客戶論文
    Synthesizing Ginsenoside Rh2 in Saccharomyces Cerevisiae Cell Factory at High-Efficiency. Cell Discov., 2019, 5: 5.
    發布時間:2019-02-28 閱讀數:920 來源:Cell Discov.
    分享到:

    Abstract:

    Synthetic biology approach has been frequently applied to produce plant rare bioactive compounds in microbial cell factories by fermentation. However, to reach an ideal manufactural efficiency, it is necessary to optimize the microbial cell factories systemically by boosting sufficient carbon flux to the precursor synthesis and tuning the expression level and efficiency of key bioparts related to the synthetic pathway. We previously developed a yeast cell factory to produce ginsenoside Rh2 from glucose. However, the ginsenoside Rh2 yield was too low for commercialization due to the low supply of the ginsenoside aglycone protopanaxadiol (PPD) and poor performance of the key UDP-glycosyltransferase (UGT) (biopart UGTPg45) in the final step of the biosynthetic pathway. In the present study, we constructed a PPD-producing chassis via modular engineering of the mevalonic acid pathway and optimization of P450 expression levels. The new yeast chassis could produce 529.0 mg/L of PPD in shake flasks and 11.02 g/L in 10 L fed-batch fermentation. Based on this high PPD-producing chassis, we established a series of cell factories to produce ginsenoside Rh2, which we optimized by improving the C3–OH glycosylation efficiency. We increased the copy number of UGTPg45, and engineered its promoter to increase expression levels. In addition, we screened for more efficient and compatible UGT bioparts from other plant species and mutants originating from the direct evolution of UGTPg45. Combining all engineered strategies, we built a yeast cell factory with the greatest ginsenoside Rh2 production reported to date, 179.3 mg/L in shake flasks and 2.25 g/L in 10 L fed-batch fermentation. The results set up a successful example for improving yeast cell factories to produce plant rare natural products, especially the glycosylated ones.


    ewm.jpg 微信公眾號
    11.jpg 移動官網
    特別聲明:禁止在未經同意情況下轉載本網站信息,BioBioPha品牌產品均由西力生物獨家生產與銷售,僅用于科學研究或企業研發!
    版權所有 2019-2020 云南西力生物技術股份有限公司 BioBioPha 滇ICP備09000810號-1滇公安備案號 53019002000069號
    技術支持:奧遠科技

    聯系客服

  • <small id="eqkgy"><blockquote id="eqkgy"></blockquote></small>
    <input id="eqkgy"><samp id="eqkgy"></samp></input>
  • <kbd id="eqkgy"><strong id="eqkgy"></strong></kbd><option id="eqkgy"></option>
  • <samp id="eqkgy"><label id="eqkgy"></label></samp>
  • <u id="eqkgy"></u>
  • av无码一区二区三区_桃花视频免费观看在线完整版_欧美人与拘牲交大全o人禾_av片在线观看无码免费